A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helmenthiasis in Kenyan children less than 2 years of age
View/ Open
Date
1989Author
Pamba HO.
Bwibo NO.
Chunge CN.
Estambale, Benson B.
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
One hundred children comprising of 57 males and 43 females aged between 8 and 24 months entered the study. 46 children had single and 54 children had multiple helminth infections. All children received albendazole 200 mg (10 ml) suspension as a single dose. Albendazole proved very effective and safe in the treatment of single and multiple helminth infections in children under 2 years of age, achieving cure rates of 100% in both Ascaris lumbricoides and Necator americanus respectively, 83% in Trichuris trichiura and 66% in Hymenolepis nana. Treatment of polyparasitism appears to be of benefit in improving nutritional status using haemoglobin concentrations as an index
URI
http://www.ncbi.nlm.nih.gov/pubmed/2591328http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16055
Citation
East Afr Med J. 1989 Mar;66(3):197-202Publisher
Department of Medical Microbiology, University of Nairobi Department of Paediatrics and Child Health, University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10378]